Novel Findings for the Development of Drug Therapy for Various Liver Diseases: Current State and Future Prospects for Our Liver Regeneration Therapy Using Autologous Bone Marrow Cells for Decompensated Liver Cirrhosis Patients
We have developed an in vivo mouse model [the green fluorescent protein (GFP) / carbon tetrachloride (CCl4) model] and reported that infused GFP-positive bone marrow cells administered via a tail vein efficiently repopulated cirrhotic liver tissue under conditions of persistent liver damage induced...
Saved in:
Main Authors: | Taro Takami (Author), Shuji Terai (Author), Isao Sakaida (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal stem cell therapies for liver cirrhosis: MSCs as "conducting cells" for improvement of liver fibrosis and regeneration
by: Atsunori Tsuchiya, et al.
Published: (2019) -
Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosis
by: Da Zhou, et al.
Published: (2023) -
Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
by: Manasa Kandula, et al.
Published: (2016) -
The expanding role of fish models in understanding non-alcoholic fatty liver disease
by: Yoichi Asaoka, et al.
Published: (2013) -
The expanding role of fish models in understanding non-alcoholic fatty liver disease
by: Yoichi Asaoka, et al.
Published: (2014)